Gene therapy for cystic fibrosis is advancing fast. Explore key biotech players, clinical progress, and its potential to ...

University of Florida scientists have helped identify a novel drug compound that selectively activates pain-altering ...

Have you been searching for a stock that might be well-positioned to maintain its earnings-beat streak in its upcoming report ...

Prescription Drug User Fee Act (PDUFA) goal date of August 27, 2025 ISELIN, N.J., April 08, 2025 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc.

Proposals that focus on one or more of the following areas will be prioritized 1: The USDA will provide funding to eligible ...

As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results ...

Calley Means is co-piloting Kennedy’s overhaul of HHS and he makes no apologies for sweeping cuts to agency's bureaucracy.

Cellular Therapies and IDRx, crossed the $1 billion mark, a notable decrease from the six seen during the same period last ...

President Trump wants to bring pharmaceutical manufacturing back to the United States. Experts warn that tariffs could result ...

Ex-vaccine regulator Peter Marks promoted "ineffective therapy that gave patients false hope, eroded trust in the regulatory ...

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They include: ...